About Farlex Pharmaceuticals
Farlex Pharmaceuticals is a Healthcare company based in India founded in 2014. Pharmaceutical products are distributed and manufactured by Farlex Pharmaceuticals in India. Its Indian entity Farlex Pharmaceuticals Private Limited reported revenue of ₹15.67 Cr. Farlex Pharmaceuticals offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Distribution, Franchise Operations and Manufacturing.
Company details
Farlex Pharmaceuticals is recognized as a provider of pharmaceutical products and healthcare solutions that are distributed across India, with a focus on safety and efficacy. Products are manufactured under ISO, WHO-GMP, and GLP certifications, ensuring adherence to international standards for quality control. Over 1000 products are handled, covering various therapeutic ranges like cardiac, diabetic, and derma products. The company is committed to delivering affordable healthcare solutions through franchise and third-party manufacturing models, while partnerships are built with clients for value-added services. Established in 2014, operations are based in Panchkula, Haryana, where products are supplied to meet patient needs nationwide.
- Headquarters India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook Instagram
- Legal Name Farlex Pharmaceuticals Pvt. Ltd
- Date of Incorporation 10 Dec, 2014
- Jurisdiction Manimajra, Chandigarh, India
- Annual Revenue₹15.67 Cr
FY 2025 · +25% YoY
- Net Profit₹22.9 Lakh
FY 2025 · 1% margin
- EBITDA₹55.4 Lakh
FY 2025 · 4% margin
Associated legal entities of Farlex Pharmaceuticals
Farlex Pharmaceuticals operates through Farlex Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Farlex Pharmaceuticals Private Limited CIN U51397CH2014PTC035315 | Active | 10 Dec 2014 | Manimajra, Chandigarh | ₹15.7 Cr | 2 | View details |
Products & Services of Farlex Pharmaceuticals
Farlex Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are distributed in various therapeutic forms to meet healthcare needs across regions.
Capsules are offered in a range that is designed to address diverse medical requirements.
Board of directors of Farlex Pharmaceuticals Private Limited (Farlex Pharmaceuticals)
Farlex Pharmaceuticals Private Limited is the primary company behind Farlex Pharmaceuticals. The board of Farlex Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Aarti, appointed in 2017. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aarti DIN 07752020 | Director | 01 Mar 2017 | 9 yrs 7 mo | Farlex Pharmaceuticals Private Limited |
| Saurabh Juneja DIN 06545637 | Director | 09 Nov 2019 | 6 yrs 11 mo | Farlex Pharmaceuticals Private Limited |
Financials of Farlex Pharmaceuticals
Figures of Farlex Pharmaceuticals Private Limited, the primary company behind Farlex Pharmaceuticals, for FY 2025. Revenue was ₹15.67 Cr (+25% year on year). Net profit was ₹22.9 Lakh (1% margin). EBITDA was ₹55.4 Lakh (4% margin). Revenue has grown at a compounded annual rate of +11% over three years and +19% over five years.
- ₹15.67 CrRevenue · FY 2025 · +25% YoY
- ₹22.9 LakhNet profit · 1% margin
- ₹55.4 LakhEBITDA · 4% margin
- ₹5 LakhPaid-up capital
- +11%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Farlex Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Farlex Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Farlex Pharmaceuticals
Farlex Pharmaceuticals was founded in 2014.
Farlex Pharmaceuticals is headquartered in India.
The primary company behind Farlex Pharmaceuticals, Farlex Pharmaceuticals Private Limited, reported revenue of ₹15.67 Cr for FY 2025, up 25% year on year.
Farlex Pharmaceuticals is recognized as a provider of pharmaceutical products and healthcare solutions that are distributed across India, with a focus on safety and efficacy. Products are manufactured under ISO, WHO-GMP, and GLP certifications, ensuring adherence to international standards for quality control. Over 1000 products are handled, covering various therapeutic ranges like cardiac, diabetic, and derma products. The company is committed to delivering affordable healthcare solutions through franchise and third-party manufacturing models, while partnerships are built with clients for value-added services. Established in 2014, operations are based in Panchkula, Haryana, where products are supplied to meet patient needs nationwide.
Farlex Pharmaceuticals offers Tablets and Capsules.
Farlex Pharmaceuticals operates through Farlex Pharmaceuticals Private Limited.
The legal entities of Farlex Pharmaceuticals currently have 2 directors, including Saurabh Juneja, Aarti.